T
TG Therapeutics
TGTX · NASDAQ · Healthcare
$49.99
+$0.44 (+0.88%) today
Loading live data...
Market Cap
$7.65B
24h Volume
$52.9M
P/E Ratio
18.2
52w High
$59.06
52w Low
$26.39
Est. AI Revenue
15%
Loading chart data...
7-Day Sparkline (Static)
About TG Therapeutics
Biotech using AI-driven clinical trial design and computational immunology for B-cell targeted therapies in autoimmune diseases and oncology.
CEO: Michael Weiss
Founded: 1993
HQ: New York, New York
Employees: 399
Performance
24 Hours+0.88%
7 Days-3.93%
30 Days-15.37%
1 Year+79.22%